Catalyst presents at JPMorgan; exhibit lacks substantive details

CATALYST PHARMACEUTICALS, INC.

Presentation at 44th Annual JPMorgan Healthcare Conference on January 12, 2026.
Filed exhibit (99.1) contains only title slide and safe harbor; no financial or strategic updates provided.
No new guidance, product milestones, or material events disclosed in the available filing text.

item 7.01 item 9.01

CATALYST PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001193125-26-009822

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.